IM Therapeutics
Jason R. Dinges is the current director at IM Therapeutics. Jason has also previously worked for Apic Bio, Inc., Bacainn Therapeutics, CELLCENTRIC LIMITED, Cognito Therapeutics, Inc., Enyo Pharma, Kezar Life Sciences, Inc., Pinteon Therapeutics, Inc., Matatu, Inc., and Morningside Technology Advisory LLC. Jason has also been an attorney at Foley & Lardner LLP from March 2007 to February 2011.
Jason R. Dinges is an American lawyer and academic. Jason has a J.D. from the University of Iowa College of Law, a Ph.D. in Political Science from Iowa State University, and a B.S. in Economics from Illinois Wesleyan University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
IM Therapeutics
IM Therapeutics is building an HLA-directed platform for new therapies. They have demonstrated early effectiveness in type 1 diabetes and are building a pipeline of targeted therapies across autoimmune diseases.